Balafoutas et al., [108] identified two peptides restricted by HLA-A2 for NY-BR-1 (p158–167 and p960–968) that could be recognized by CD8+ T cells derived from patients with BC. The gene discussed is ANKRD30A; the disease is breast cancer.